<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Bloemberg GV</dc:creator>
  <dc:creator>Keller PM</dc:creator>
  <dc:creator>Stucki D</dc:creator>
  <dc:creator>Stuckia D</dc:creator>
  <dc:creator>Trauner A</dc:creator>
  <dc:creator>Borrell S</dc:creator>
  <dc:creator>Latshang T</dc:creator>
  <dc:creator>Coscolla M</dc:creator>
  <dc:creator>Rothe T</dc:creator>
  <dc:creator>Hömke R</dc:creator>
  <dc:creator>Ritter C</dc:creator>
  <dc:creator>Feldmann J</dc:creator>
  <dc:creator>Schulthess B</dc:creator>
  <dc:creator>Gagneux S</dc:creator>
  <dc:creator>Böttger EC</dc:creator>
  <dc:date>2015</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Treatment of multidrug-resistant Mycobacterium tuberculosis is a challenge. This letter describes the emergence of resistance to new therapies, bedaquiline and delamanid.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://sonar.ch/global/documents/35702</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1056/NEJMc1505196</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/26559594</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:source>The New England journal of medicine. - 2015</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Antitubercular Agents</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Diarylquinolines</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Drug Resistance, Bacterial</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Drug Therapy, Combination</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Male</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Mutation</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Mycobacterium tuberculosis</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Nitroimidazoles</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Oxazoles</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Tuberculosis, Multidrug-Resistant</dc:subject>
  <dc:title xmlns:ns12="xml" ns12:lang="en">Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>